PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function
Mohamed A. Ghonim(St. Jude Children's Research Hospital), A. Hamid Boulares(Louisiana State University Health Sciences Center New Orleans)
Cited by 48
Related Papers
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
|British Journal of Pharmacology|2017|210
PDZK1 Is a Novel Factor in Breast Cancer That Is Indirectly Regulated by Estrogen through IGF-1R and Promotes Estrogen-Mediated Growth
|Molecular Medicine|2013|101
Correlation between PDZK1, Cdc37, Akt and Breast Cancer Malignancy: The Role of PDZK1 in Cell Growth through Akt Stabilization by Increasing and Interacting with Cdc37
|Molecular Medicine|2014|40